Meropenem Qilu

Meropenem, the active ingredient in Meropenem Qilu, is a carbapenem antibiotic presented as a sterile powder for reconstitution for intravenous use. It treats severe bacterial infections such as intra‑abdominal infections, hospital‑acquired pneumonia, meningitis, and sepsis in adult and pediatric patients when other therapies are unsuitable.

GNH USA supplies Meropenem Qilu as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meropenem is a broad‑spectrum carbapenem used for serious bacterial infections across several organ systems.

- Complicated intra‑abdominal infections: provides bactericidal activity against mixed aerobic and anaerobic pathogens. - Complicated urinary tract infections: eradicates resistant Gram‑negative organisms causing severe UTIs. - Hospital‑acquired pneumonia: treats ventilator‑associated and other nosocomial pneumonias. - Meningitis: penetrates the cerebrospinal fluid to eliminate causative bacteria. - Severe sepsis: offers rapid bacterial clearance in systemic infections.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Rash: erythematous skin eruptions. - Infusion site reactions: pain, erythema, or phlebitis. - Elevated liver enzymes: transient transaminase increase. - Headache: mild to moderate intensity.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disease. - Anaphylaxis: acute hypersensitivity requiring immediate intervention. - Clostridioides difficile colitis: severe diarrhea due to gut flora disruption. - Severe neutropenia: marked reduction in neutrophil count. - Renal toxicity: worsening kidney function in susceptible individuals. - Hypersensitivity reactions: including Stevens‑Johnson syndrome.

Careful assessment and monitoring are essential when using Meropenem.

- Renal function: adjust dose in patients with impaired clearance. - Allergy history: avoid if known hypersensitivity to carbapenems or β‑lactams. - Pregnancy: use only when benefits outweigh potential risks. - Concomitant valproic acid: monitor for decreased serum levels. - Superinfection: watch for fungal or opportunistic bacterial overgrowth. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with several drugs, requiring vigilance.

Major Interactions (Avoid): - Valproic acid: reduces antiepileptic serum concentrations. - Phenobarbital: may increase meropenem clearance, lowering efficacy. - Renally toxic agents (e.g., aminoglycosides): heightened risk of kidney injury.

Moderate Interactions (Monitor Closely): - Loop diuretics: monitor renal function and electrolytes. - Aminoglycosides: assess for additive nephrotoxicity. - Anticoagulants (warfarin): observe INR for potential alterations.